Anders Bendsen Spohr

Bioindustrial Investments, Life Sciences Operating Committee
Senior Partner, Head of Bioindustrial Investments

Anders joined Novo Holdings A/S in 2017.
Anders is Senior Partner and Head of the Bioindustrial Investments Team.

Prior to joining Novo Holdings, Anders was employed as VP in Xellia Pharmaceuticals heading up the Global Product Supply. Other previous employments include EVP, Global Product Supply at Leo Pharma A/S and VP Global Supply Chain at Novozymes A/S.

Anders holds a PhD in Biotechnology and a MSc in Chemical Engineering from Technical University of Denmark as well as a graduate diploma in Business Administration (International Business) from Copenhagen Business School.